Basics 10x Genomics, Inc. IPO Date: September 12, 2019 Sector: Healthcare Industry: Health Information Services Market Cap: $2.25B Activated in VL: True Average Daily Range Avg Daily Range: $1.78 | 2.78% Avg Daily Range (30 D): $0.46 | 2.99% Avg Daily Range (90 D): $0.39 | 2.86% Institutional Daily Volume Avg Daily Volume: 1.2M Avg Daily Volume (30 D): 2.58M Avg Daily Volume (90 D): 2.43M Trade Size Avg Trade Size (Sh.): 66 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 74 Institutional Trades Total Inst.Trades: 4,643 Avg Inst. Trade: $3.81M Avg Inst. Trade (30 D): $2.82M Avg Inst. Trade (90 D): $3M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $6.86M Avg Closing Trade (30 D): $5.29M Avg Closing Trade (90 D): $4.81M Avg Closing Volume: 154.17K     News Dec 1, 2025 @ 3:00 PM Tumor Transcriptomics Research Report 2025: An $8.... Source: Researchandmarkets.Com Oct 24, 2025 @ 4:25 PM Lancaster Opens $7 Million Position in 10x Genomic... Source: Emma Newbery Oct 13, 2025 @ 8:51 AM Single-cell Analysis Market to Reach USD 12.29 Bil... Source: Sns Insider Jun 12, 2025 @ 8:58 AM Molecular Diagnostics for Cancer Market Research 2... Source: Researchandmarkets.Com Jan 30, 2025 @ 8:30 AM [Latest] Global Single Cell Multiomics Market Size... Source: Custom Market Insights Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.63 $-.22 $.28 Diluted EPS $-.63 $-.22 $.28 Revenue $ 641.81M $ 149M $ 172.91M Gross Profit $ 441.79M $ 100.31M $ 125.08M Net Income / Loss $ -76.32M $ -27.47M $ 34.54M Operating Income / Loss $ -91.28M $ -32.24M $ 30.13M Cost of Revenue $ 200.02M $ 48.7M $ 47.82M Net Cash Flow $ 34.55M $ 35M $ 20.65M PE Ratio